Please Wait...

ClinDebit

Pay Your Clinical Trial Subjects Promptly and Digitally

Eliminate the need for sites to manually pay and account for subject payments and provide prepaid debit cards, allowing sites to compensate subjects quickly and efficiently through an online, automated application. Payments can be loaded onto subject debit cards with funds available for use in real-time.

With Bioclinica Patient Reimbursement, you can:

  • Eliminate the need for site accounting
  • Reduce costs and transactional fees
  • Make payments directly to subjects

Card is issued by The Bancorp Bank, Member FDIC, pursuant to a license from Visa U.S.A. Inc.

Download our ClinDebit Data sheet

ADDITIONAL RESOURCES

Bioclinica Financial Lifecycle Solutions Platform

Download Overview SHEET

6 Reasons Why You Should Choose Bioclinica's Financial Lifecycle Solutions

Download Infographic

Challenges with Cash Management and Reforecasting Clinical Trials

Download eBook

ROI Initiative: A Technology Solution for Investigator Payments

Download eBook

Embracing Clinical Trial Technology

Download eBook

Competitive Advantages of Accelerating Payments to Investigative Sites

Download eBook

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (18 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (19 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (19 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (19 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (19 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (19 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices